Adhezion Biomedical Completes Series A Financing

WYOMISSING, Pa. Adhezion Biomedical LLC, a privately held medical device manufacturer that develops and manufactures adhesive and anti-microbial sealant products for medical applications, raised $2.1M in second tranche of $5.25M Series A round.

Adhezion Biomedicals proprietary formulation can be used in a variety of applications including as an anti-microbial surgical sealant that creates a protective barrier to prevent infection, or to bond skin tissue, replacing sutures, staples and bandages. The products require no refrigeration or blending, dry faster, and are very flexible. They are sold under the SurgiSeal, FloraSeal and DermaSeal brands, targeted to surgeons and physicians.

This Series A investment confirms the strength of our company and the efficacy of our approach, said Pete Molinaro, CEO of Adhezion Biomedicals. Our patented OctylFlex monomer process can be used in an extremely wide array of topical product applications, addressing skin lacerations, incisions and plastic surgery. It meets the needs of surgeons and patients seeking less disruptive, more natural healing solutions that are both durable and versatile.

Liberty Venture Partners is pleased to invest in Adhezion Biomedical. We are very impressed with the caliber of its management team, and its technology and products. We look forward to partnering with them to build a world-class company, said Katherine Crothall, Principal, Liberty Venture Partners.

About Liberty Venture Partners:

Liberty Venture Partners is a Philadelphia-based venture capital company with an investment focus in health care and information technology. Liberty Venture Partners provides financing to growth-stage and expansion-stage enterprises on a national basis, with a concentration on the Mid-Atlantic region.

About Adhezion Biomedical, LLC

Adhezion Biomedical is a privately held medical device company based in Wyomissing, PA. Adhezion is committed to developing and manufacturing adhesive and anti-microbial sealant products that are both highly differentiated and proprietary. SurgiSeal, the Companys cyanoacrylate-based topical skin adhesive, is being introduced to European markets and is currently seeking approval for the product in the U.S. To learn more, visit www.adhezion.com.